The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C
Open accessAbstract
Interferon (IFN)-alpha has been used to investigate pathways by which innate immune cytokines influence the brain and behaviour. Previous studies suggest that altered basal ganglia function may contribute to IFN-alpha-induced neuropsychological and behavioural changes. To further examine IFN-alpha effects on neuropsychological functions related to basal ganglia (as well as other brain regions), and explore the relationship between altered neuropsychological function and IFN-alpha-induced depression and fatigue, a selected subset of the Cambridge Neuropsychological Test Automated Battery was administered to 32 hepatitis C patients at baseline (Visit 1) and following approximately 12 weeks (Visit 2) of either no treatment (n=12) or treatment with IFN-alpha plus ribavirin (n=20). Symptoms of depression and fatigue were assessed using the Montgomery-Asberg Depression Rating Scale and the Multidimensional Fatigue Inventory. Compared to control subjects, patients treated with IFN-alpha/ribavirin exhibited significant decreases in motor speed as measured in the simple and five-choice movement segments of the CANTAB reaction time task and slower response times in the rapid visual information processing task, a task of sustained attention. Decreased motor speed on the five-choice movement segments of the reaction time task was in turn correlated with increased symptoms of depression and fatigue (R=0.47, p<0.05 and R=0.48, p<0.05, respectively). IFN-alpha/ribavirin treatment had no effects on executive function, decision time in the reaction time task, or target detection accuracy in the sustained attention task. Motor slowing and its correlation with psychiatric symptoms suggest that altered basal ganglia function may contribute to the pathogenesis of IFN-alpha-induced behavioural changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This study used IFN-α (plus ribavirin) as an inflammatory stimulus and measured planning ability with the Stockings of Cambridge task, and no effect of inflammation on planning ability was observed (Majer et al., 2008).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Majer et al., 2008
In the citing paper
“IFN-α (plus ribavirin) therapy led to significant decreases in motor speed among patients with hepatitis C (Majer et al., 2008).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Majer et al., 2008
In the citing paper
“Notably, decreased motor speed in this study was also associated with increased symptoms of depression and fatigue (Majer et al., 2008).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Majer et al., 2008
In the citing paper
“Notably, decreased motor speed in this study was also associated with increased symptoms of depression and fatigue (Majer et al., 2008).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Majer et al., 2008
In the citing paper
“The fatigue of depression, which is often a residual symptom of SSRI therapy, is a prominent feature of cytokine-induced depression, and may represent cytokine effects on the basal ganglia and dopamine (DA) function (Capuron et al., 2001, Majer et al., 2008, Capuron et al., 2009).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Majer et al., 2008
In the citing paper
“depression and fatigue are the main side effects of treatment with IFN-α (111, 112).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Smets, E. M. A., Garssen, B., Bonke, B., & de Haes, J. C. J. M. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)00125-o · Cited by 3,622
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS
Mink, J. W. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00042-1 · Cited by 2,478
The Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 2,016
Basal ganglia and cerebellar loops: motor and cognitive circuits
Middleton, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00040-5 · Cited by 1,940
The Biochemical Basis of Neuropharmacology.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-575_2 · Cited by 1,882
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,284
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Cited by
Sorted by citations
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Self-citationInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Self-citationRaison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630
Self-citationInflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 474
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 447
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 413
Self-citationCapuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
Self-citationRaison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., Vogt, G. J., Massung, B., & Miller, A. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.010 · Cited by 367
Self-citationSalamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Self-citationShelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 264
Self-citationThe evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253
Self-citationHaroon, E., Fleischer, C. C., Felger, J. C., Chen, X., Woolwine, B. J., Patel, T., Hu, X. P., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.206 · Cited by 250
Self-citationInflammation and the dimensions of depression: A review
Majd, M., Saunders, E. F. H., & Engeland, C. G. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100800 · Cited by 229
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
Goldsmith, D. R., Bekhbat, M., Mehta, N. D., & Felger, J. C. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.003 · Cited by 229
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
Self-citationRaison, C. L., Borisov, A. S., Woolwine, B. J., Massung, B., Vogt, G., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.58 · Cited by 183
Self-citationTowards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Miller, B. J., & Goldsmith, D. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.211 · Cited by 182
Felger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
Self-citationDooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176
Capuron, L., Fornwalt, F. B., Knight, B. T., Harvey, P. D., Ninan, P. T., & Miller, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.017 · Cited by 164
Self-citationMorris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Self-citationMechanisms by which sleep disturbance contributes to osteoarthritis pain: A conceptual model
Smith, M. T., Quartana, P. J., Okonkwo, R., & Nasir, A. (2009) · Current Pain and Headache Reports · doi:10.1007/s11916-009-0073-2 · Cited by 152
Goldsmith, D. R., Haroon, E., Woolwine, B. J., Jung, M. Y., Wommack, E. C., Harvey, P. D., Treadway, M. T., Felger, J. C., & Miller, A. H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.025 · Cited by 150
Self-citationRaison, C. L., Rye, D. B., Woolwine, B. J., Vogt, G. J., Bautista, B. M., Spivey, J. R., & Miller, A. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.019 · Cited by 116
Self-citationMott, A. M., Nunes, E. J., Collins, L. E., Port, R. G., Sink, K. S., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1441-z · Cited by 116
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Lasselin, J., Lekander, M., Axelsson, J., & Karshikoff, B. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.005 · Cited by 106
Salamone, J. D., Farrar, A. M., Font, L., Patel, V. B., Schlar, D. E., Nunes, E. J., Collins, L. E., & Sager, T. N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.021 · Cited by 105
Firth, J., Veronese, N., Cotter, J., Shivappa, N., Hébert, J. R., Ee, C., Smith, L., Stubbs, B., Jackson, S. E., & Sarris, J. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00350 · Cited by 104
Yohn, S. E., Arif, Y., Haley, A., Tripodi, G., Baqi, Y., Müller, C. E., Miguel, N. S., Correa, M., & Salamone, J. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4392-9 · Cited by 93
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 94
Nunes, E. J., Randall, P. A., Santerre, J. L., Given, A. M., Sager, T. N., Correa, M., & Salamone, J. D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.068 · Cited by 91
Draper, A., Koch, R. M., van der Meer, J. W., Apps, M. A. J., Pickkers, P., Husain, M., & van der Schaaf, M. E. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.231 · Cited by 94
Influences of dopaminergic system dysfunction on late-life depression
Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01265-0 · Cited by 89
Sarkar, S., Jiang, Z., Evon, D. M., Wahed, A. S., & Hoofnagle, J. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.030 · Cited by 83
In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
Tournier, B. B., Tsartsalis, S., Ceyzériat, K., Garibotto, V., & Millet, P. (2020) · Cells · doi:10.3390/cells9091941 · Cited by 79
Worden, L. T., Shahriari, M., Farrar, A. M., Sink, K. S., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1396-0 · Cited by 79
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes
Lasselin, J., Layé, S., Dexpert, S., Aubert, A., Gonzalez, C., Gin, H., & Capuron, L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.03.003 · Cited by 77
Self-citationSekio, M., & Seki, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu005 · Cited by 75
Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms
Korte, S. M., & Straub, R. H. (2019) · Rheumatology · doi:10.1093/rheumatology/kez413 · Cited by 71
Raison, C. L., & Miller, A. H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.194 · Cited by 71
Self-citationThe possible role of the kynurenine pathway in anhedonia in adolescents
Gabbay, V., Ely, B. A., Babb, J. S., & Liebes, L. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0685-7 · Cited by 69
Haroon, E., Felger, J. C., Woolwine, B. J., Chen, X., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.12.004 · Cited by 63
Self-citationPérez‐Sánchez, G., Becerril‐Villanueva, E., Arreola, R., Martínez-Levy, G. A., Hernández, M. E., Velasco-Velázquez, M. A., Álvarez-Herrera, S., Cruz-Fuentes, C. S., Palacios, L., de la Peña, F., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/4074051 · Cited by 62
Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression
Casaril, A. M., Dantzer, R., & Orth, C. B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.725547 · Cited by 62
Felger, J. C., Cole, S. W., Pace, T. W. W., Hu, F., Woolwine, B. J., Doho, G., Raison, C. L., & Miller, A. H. (2011) · Psychological Medicine · doi:10.1017/s0033291711002868 · Cited by 56
Self-citationPalé, L. A., Caballero, J. L., Buxareu, B. S., Salgado, P., & Pérez, V. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.07.008 · Cited by 50
Arnett, S., & Clark, I. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.004 · Cited by 49
Vichaya, E. G., & Dantzer, R. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.01.008 · Cited by 47
Huckans, M. S., Fuller, B. E., Wheaton, V. R., Jaehnert, S., Ellis, C. C., Kolessar, M., Kříž, D., Anderson, J. R., Berggren, K., Olavarria, H., et al. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.07.020 · Cited by 45
Piser, T. M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.02.006 · Cited by 45
Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry
Thylur, D. S., & Goldsmith, D. R. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000326 · Cited by 42
Managing systemic symptoms in chronic liver disease
Newton, J. L., & Jones, D. E. J. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60006-3 · Cited by 40
Salamone, J. D., Correa, M., Farrar, A. M., Nunes, E. J., & Collins, L. E. (2010) · Future Neurology · doi:10.2217/fnl.10.19 · Cited by 40
Can we vaccinate against depression?
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.018 · Cited by 39
Self-citationIntegrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Hersey, M., Hashemi, P., & Reagan, L. P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15392 · Cited by 41
Rance, J., Newland, J., Hopwood, M., & Treloar, C. (2011) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.10.003 · Cited by 37
Risk factors for the development of depression in patients with hepatitis C taking interferon-α
Smith, K. J. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13917 · Cited by 35
Salamone, J. D., Correa, M., Yohn, S. E., Yang, J.-H., Somerville, M., Rotolo, R. A., & Presby, R. E. (2017) · Motivation Science · doi:10.1037/mot0000070 · Cited by 35
Bekhbat, M., Goldsmith, D. R., Woolwine, B. J., Haroon, E., Miller, A. H., & Felger, J. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01258-z · Cited by 34
Self-citationDopamine, effort, and decision making: Theoretical comment on Bardgett et al. (2009).
Salamone, J. D. (2009) · Behavioral Neuroscience · doi:10.1037/a0015381 · Cited by 31
Hilsabeck, R. C., Anstead, G. M., Webb, A., Hoyumpa, A., Ingmundson, P. T., Holliday, S., Zhang, Q., Casas, Á., Jovel, M., & Stern, S. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.017 · Cited by 31
Saad, S. A., Dunn, L. B., Koetters, T., Dhruva, A., Langford, D. J., Merriman, J. D., West, C. M., Paul, S. M., Cooper, B. A., Cataldo, J. K., et al. (2014) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2014.03.009 · Cited by 30
Lebeña, A., Vegas, Ó., Gómez-Lázaro, E., Arregi, A., Garmendia, L., Beitia, G., & Azpiroz, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.045 · Cited by 34
Mental Quality of Life Is Related to a Cytokine Genetic Pathway
Schoormans, D., Radonic, T. R., de Witte, P., Groenink, M., Azim, D., Lutter, R., Mulder, B. J. M., Sprangers, M. A. G., & Zwinderman, A. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045126 · Cited by 29
Aging as a Context for the Role of Inflammation in Depressive Symptoms
Straka, K., Tran, M.-L. M., Millwood, S. N., Swanson, J., & Kuhlman, K. R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.605347 · Cited by 26
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Mancini, M., Natoli, S., Gardoni, F., Luca, M. D., & Pisani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065618 · Cited by 24
Muzik, O., & Diwadkar, V. A. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.015 · Cited by 25
Cognitive function and endogenous cytokine levels in children with chronic hepatitis C
Faddan, N. H. A., Shehata, G. A., Hafeez, H. A. A. E., Mohamed, A. O., Hassan, H., & Sameea, F. A. E. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12373 · Cited by 23
Marcondes, M. C. G., Flynn, C. T., Huitrón‐Reséndiz, S., Watry, D. D., Zandonatti, M. A., & Fox, H. S. (2009) · AIDS · doi:10.1097/qad.0b013e32832c4af0 · Cited by 22
Benveniste, H., Zhang, S., Reinsel, R. A., Li, H., Lee, H., Rebecchi, M. J., Moore, W., Johansen, C., Rothman, D. L., & Bilfinger, T. V. (2012) · Europe PMC (PubMed Central) · Cited by 20
Cognitive impairments in HCV infection: From pathogenesis to neuroimaging
Amirsardari, Z., Rahmani, F., & Rezaei, N. (2019) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2019.1652728 · Cited by 20
Beyer, D. K. E., Mattukat, A., & Freund, N. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00212-2 · Cited by 18
Multidimensional Fatigue Inventory in People With Hepatitis B Infection
Saffari, M., Naderi, M. K., Piper, C. N., & Koenig, H. G. (2017) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000250 · Cited by 17
Cytokines as Neuromodulators: Insights From Experimental Studies With Humans and Nonhuman Primates
Martins, D., & Harrison, N. A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.06.037 · Cited by 16
Bekhbat, M., Block, A. M., Dickinson, S. Y., Tharpd, G. K., Bosinger, S. E., & Felger, J. C. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.010 · Cited by 13
Zervides, K. A., Grenmyr, E., Janelidze, S., Linge, P., Nystedt, J., Nilsson, P. C., Sundgren, P. C., Hansson, O., Bengtsson, A. A., & Jönsen, A. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03539-2 · Cited by 13
Hassaan, S. H., Darweesh, A. E. D. M., Khalifa, H., Ramadan, H. K., Hassany, S. M., Ahmed, G. K., & Moustafa, E. F. A. (2019) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217419858277 · Cited by 13
The Role of Attachment Style and Depression in Patients with Hepatitis C
Sockalingam, S., Blank, D., Jarad, A. A., Alosaimi, F. D., Hirschfield, G. M., & Abbey, S. E. (2012) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-012-9335-y · Cited by 12
Neurocognitive Performance in Depressed Patients with low-grade inflammation and somatic symptoms
Kaşer, M., Foley, É. M., & Khandaker, G. M. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100409 · Cited by 12
Handke, A. E., Axelsson, J., Benson, S., Boy, K., Weskamp, V., Hasenberg, T., Remy, M., Hebebrand, J., Föcker, M., Brinkhoff, A., et al. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100130 · Cited by 11
Zhu, L., Lu, W., Gamoso, W., Tan, Y., Johnson, C. K., & Grace, X. (2022) · Brain Sciences · doi:10.3390/brainsci12020188 · Cited by 10
Lipopolysaccharide Effects on Neurotransmission: Understanding Implications for Depression
Batey, L., Baumberger, B., Khoshbouei, H., & Hashemi, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00591 · Cited by 9
Golabi, P., Elsheikh, E. B., Karrar, A., Estep, J. M., Younossi, I. M., Stepanova, M., Gerber, L. H., & Younossi, Z. M. (2016) · Medicine · doi:10.1097/md.0000000000005066 · Cited by 9
Larsen, J. B., Reitan, S. K., Løberg, E., Rettenbacher, M. A., Bruserud, Ø., Larsen, T. K., Anda, L. G., Bartz-Johannessen, C. A., Johnsen, E., & Kroken, R. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100392 · Cited by 9
Wang, M., Yu, X., & Gao, Q. (2024) · Current Medical Science · doi:10.1007/s11596-024-2859-1 · Cited by 8
Miller, T. R., Weiss, J. J., Bräu, N., Dieterich, D. T., Stivala, A. C., & Mindt, M. R. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0494-8 · Cited by 8
Suchting, R., Razouq, D., Jose, L., Nascimento, F., Wardle, M. C., Soares, J. C., Teixeira, A. L., & Selvaraj, S. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.03.019 · Cited by 7
Bassiony, M. M., Yousef, A. M., Youssef, U. M., El-deen, G. M. S., Abdelghani, M., Al-Gohari, H., Fouad, E., & El-Shafaey, M. (2015) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217415605029 · Cited by 7
Carr, A. C., Vissers, M. C. M., Vissers, M. C. M., Cook, J. S., & Cook, J. S. (2015) · Case Reports in Clinical Pathology · doi:10.5430/crcp.v2n2p57 · Cited by 7
Bassiony, M. M., Yousef, A. M., Raya, Y., El-Shabrawi, A., Fouad, E. A., & El-Shafeey, M. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1064964 · Cited by 6
The Role of Immune System in Depression Disorder
Hoseinzadeh, F., Abadi, P. H., Agheltar, M., Aghayinejad, A., Torabian, F., Rezayat, A. A., Akbarzadeh, F., & Rahimi, H. R. (2016) · Health · doi:10.4236/health.2016.815167 · Cited by 6
Santos‐Lima, C., Souza‐Marques, B., Vieira, F., Schinoni, M. I., Quarantini, L. C., & Abreu, N. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13584 · Cited by 6
Inflammatory stress responses and future mental health outcomes in people with type 2 diabetes
Panagi, L., Poole, L., Steptoe, A., & Hackett, R. A. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100472 · Cited by 6
Smith, K. J., Norris, S., McKiernan, S. M., Hynes, B., O’Dwyer, A. M., & O’Mara, S. M. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.03.001 · Cited by 5
Vaccination and Immunotherapy for Major Depression
Evrensel, A., Ünsalver, B. Ö., Ceylan, M. E., & Tarhan, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_25 · Cited by 5
Metadata
- Authors
- Majer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H.
- Affiliations
- Emory University (US)
- Corresponding author
- Miller, Andrew H.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 22
- Issue
- 6
- Pages
- 870-880
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC2497339
- OpenAlex
- W2058231748
- Cited by
- 124
- References
- 93
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 11 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 13 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 16
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (UL1TR000454)
- National Heart, Lung, and Blood Institute (R01HL073921)
- National Institute of Mental Health (R01MH067990, K05MH069124)
- National Center for Research Resources (MO-1-RR-00039, M01RR000039)
- NIH Clinical Center
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- interferon-alpha, chronic hepatitis C, motor slowing, depression, fatigue, basal ganglia, neuropsychological outcomes, ribavirin, reaction time, sustained attention
- MeSH terms
- Adult, Antiviral Agents, Basal Ganglia, Depression, Fatigue, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Prospective Studies, Psychiatric Status Rating Scales, Reaction Time, Regression Analysis, Ribavirin, Interferon-alpha, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
